Table 2 General clinical condition of the group A and group B at admission
From: Role of enteral nutrition in nonthyroidal illness syndrome: a retrospective observational study
Parameters | Group A (N = 66) | Group B (N = 14) | P |
|---|---|---|---|
Gender (Male, n %) | 48 (72.72 %) | 10 (71.43 %) | 0.944 |
Age (yrs, mean ± SD) | 47.69 ± 13.03 | 48.71 ± 15.17 | 0.708 |
Severity scores, mean ± SD | |||
APACHE II score | 15.64 ± 1.29 | 16.47 ± 2.87 | 0.248 |
Primary diagnosis (n %) | 0.679 | ||
Trauma/Surgery complication | 44 (66.67 %) | 6 (42.86 %) | |
IBD | 12 (18.18 %) | 4 (28.57 %) | |
Pancreatitis | 4 (6.06 %) | 2 (14.29 %) | |
Others | 6 (9.09 %) | 2 (14.29 %) | |
Fistula Location | 0.139 | ||
Duodenum | 10 (15.15 %) | 2 (14.29 %) | |
Colon | 16 (24.24 %) | 0 (0.00 %) | |
Small bowel | 28 (42.42 %) | 4 (28.57 %) | |
Multiple visceraa | 12 (18.18 %) | 8 (57.14 %) | |
Underlying disease, n (%) | 0.634 | ||
Untreated cancer | 6 (9.09 %) | 2 (14.29 %) | |
DM | 20 (30.30 %) | 4 (28.57 %) | |
COPD | 12 (18.18 %) | 0 (0.00 %) | |
None | 28 (42.42 %) | 8 (57.14 %) | |
Time for initiation of enteral nutrition, n (%) | 0.013 | ||
< 7 day | 18 (27.27 %) | 2 (14.29 %) | |
7–14 days | 28 (42.42 %) | 2 (14.29 %) | |
15–21 days | 18 (27.27 %) | 4 (28.57 %) | |
>22 days | 2 (3.03 %) | 6 (42.86 %) | |
Hospital cost, median (IQR), dollar | 28,502.82 (31,494) | 32,042.04 (28,492) | 0.003 |
WBC, ×109/L, mean ± SD | 10.30 ± 6.31 | 10.54 ± 1.47 | 0.123 |
CRP, mg/L, mean ± SD | 73.53 ± 62.11 | 71.82 ± 25.11 | 0.223 |
RBC, ×109/L, mean ± SD | 3.21 ± 0.73 | 3.16 ± 0.54 | 0.705 |
GPT, U/L, mean ± SD | 46.62 ± 25.36 | 44.27 ± 17.96 | 0.512 |
PCs, ×109/L, mean ± SD | 126.48 ± 82.38 | 122.66 ± 78.53 | 0.189 |
Cr, umol/L, mean ± SD | 56.28 ± 49.98 | 53.50 ± 34.59 | 0.661 |